Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 08, 2020 16:05 ET | Source: Emisphere Technologies, Inc.

Novo Nordisk Completes Acquisition of Emisphere Technologies for $1.35 Billion

ROSELAND, N.J., Dec. 08, 2020 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (“Emisphere” or the “Company”) today announced the completion of the previously announced transaction whereby Novo...
November 06, 2020 08:00 ET | Source: Emisphere Technologies, Inc.

Novo Nordisk to Acquire Emisphere Technologies for $1.35 Billion

ROSELAND, N.J., Nov. 06, 2020 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (“Emisphere” or the “Company”) today announced that it has entered into a definitive agreement with Novo Nordisk A/S...
April 06, 2020 08:30 ET | Source: Emisphere Technologies, Inc.

EMISPHERE DEVELOPMENT UPDATE

ROSELAND, N.J., April 06, 2020 (GLOBE NEWSWIRE) -- Novo Nordisk announced the European Commission (EC) has granted marketing authorization for Rybelsus®, (oral semaglutide), for the treatment of...
September 20, 2019 12:31 ET | Source: Emisphere Technologies, Inc.

Emisphere Development Update

ROSELAND, N.J., Sept. 20, 2019 (GLOBE NEWSWIRE) -- Novo Nordisk announced today the Federal Food and Drug Administration (FDA) has approved Rybelsus, a semaglutide tablet, for the treatment of...
September 10, 2019 08:30 ET | Source: Emisphere Technologies, Inc.

Emisphere Announces Leadership Changes

ROSELAND, N.J., Sept. 10, 2019 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (OTCMKTS: EMIS) today announced that Alan L. Rubino, will retire as President and Chief Executive Officer (CEO)...